Potential and limitations of polysaccharide vaccines in infancy

This publication has 29 references indexed in Scilit:

• Multidrug-resistant typhoid fever in children
  The Pediatric Infectious Disease Journal, 1994
• Salmonella typhi infection in children younger than five years of age
  The Pediatric Infectious Disease Journal, 1993
• Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella Typhi
  New England Journal of Medicine, 1987
• PNEUMOCOCCAL VACCINE PREVENTS DEATH FROM ACUTE LOWER-RESPIRATORY-TRACT INFECTIONS IN PAPUA NEW GUINEAN CHILDREN
  The Lancet, 1986
• Tetravalent (A, C, Y, W 135) meningococcal vaccine in children: Immunogenicity and safety
  Vaccine, 1985
• Vaccination Against Streptococcus pneumoniae in Childhood: Lack of Demonstrable Benefit in Young Australian Children
  The Journal of Infectious Diseases, 1984
• SAFETY AND IMMUNOGENICITY OF A NEW HAEMOPHILUS INFLUENZAE TYPE b VACCINE IN INFANTS UNDER ONE YEAR OF AGE
  The Lancet, 1981
• Use of Pneumococcal Vaccine for Prevention of Recurrent Acute Otitis Media in Infants in Boston
  Clinical Infectious Diseases, 1981
• Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age
  New England Journal of Medicine, 1977
• Interim Report of a Controlled Field Trial of Immunization with Capsular Polysaccharides of Haemophilus influenzae Type band Group C Neisseria meningitidis in Mecklenburg County, North Carolina (March 1974-March 1976)
  The Journal of Infectious Diseases, 1977